Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
Polyrizon (PLRZ) previously announced the initiation of preclinical studies for intranasal Naloxone, a life-saving opioid overdose treatment.
Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating ...
These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...
Naloxone has been a cornerstone in the fight against the opioid epidemic, which has seen a surge in fatalities due to synthetic opioids like fentanyl. The intranasal delivery method of Naloxone ...
A toddler in Airway Heights was exposed to fentanyl and revived with Narcan, highlighting the growing opioid crisis and the ...
11don MSN
Port Jefferson stores are now using Narcan nasal spray after a town Chamber of Commerce meeting that included a presentation ...
These preclinical studies mark a step forward in evaluating Polyrizon's Trap and Targetâ„¢ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly reverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results